Metraipolis › archive › dc_33467a74e644

European Health Technology Assessment Considerations Related to Gene Therapies in Eyecare: The Neovascular Age-Related Macular Degeneration Example — Europe PMC PMID:40989744

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40989744
DOI
10.3390/jmahp13030042
License (as archived)
solo-consultazione
Archived
2026-11-10T08:06:34.069Z
SHA-256 of the archived text
5984cf2caee19de3b326f1a9d2067925671fd8accf19a05217039bd921d65b8e
Stable URL of this page
https://metraipolis.com/documento/dc_33467a74e644

How to cite

European Health Technology Assessment Considerations Related to Gene Therapies in Eyecare: The Neovascular Age-Related Macular Degeneration Example — Europe PMC PMID:40989744 — Europe PMC (en), https://europepmc.org/article/MED/40989744 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_33467a74e644 (Metraipolis archive dc_33467a74e644, sha256 5984cf2caee19de3b326f1a9d2067925671fd8accf19a05217039bd921d65b8e)
BibTeX
@misc{dc33467a74e644,
  title = {European Health Technology Assessment Considerations Related to Gene Therapies in Eyecare: The Neovascular Age-Related Macular Degeneration Example — Europe PMC PMID:40989744},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40989744},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_33467a74e644; sha256 5984cf2caee19de3b326f1a9d2067925671fd8accf19a05217039bd921d65b8e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40989744. Agents can read the archived copy with the MCP tool read_document.